MISTY SEABORN: Open Payments
NPI 1689196990 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 53 payments from 15 companies in 2025. Trend: 2023 $948 · 2024 $732 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 8 | $303 |
| Dexcom, Inc. | 5 | $224 |
| Lilly USA, LLC | 11 | $142 |
| Tandem Diabetes Care, Inc. | 5 | $99 |
| Corcept Therapeutics | 5 | $85 |
| Novo Nordisk Inc | 3 | $73 |
| Insulet Corporation | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| BETA BIONICS, INC. | 2 | $49 |
| Amgen Inc. | 3 | $48 |
Products named: TWIIST, DEXCOM G7 GSS (161), MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Korlym, Dexcom G6 Transmitter, Wegovy, Omnipod.
Industry payments across SC — which companies pay providers there.
